{"transactions":[{"id":1114502,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":78614,"kind":"person","name":"Gilbert Mark John","position":1,"cik":"0001897698","reported_name":"Gilbert Mark John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-11T20:05:11.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on June 10, 2026."}],"balance_after":12500,"derivative":{"exercise_price":0.33,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001641172-25-014690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014690/ownership.xml","form_type":"4"}},{"id":1485958,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":78614,"kind":"person","name":"Gilbert Mark John","position":1,"cik":"0001897698","reported_name":"Gilbert Mark John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T21:00:16.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on June 6, 2025."}],"balance_after":12500,"derivative":{"exercise_price":2.63,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-24-023147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315224023147/ownership.xml","form_type":"4"}},{"id":1874139,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":78614,"kind":"person","name":"Gilbert Mark John","position":1,"cik":"0001897698","reported_name":"Gilbert Mark John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T20:15:42.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on May 25, 2024."}],"balance_after":12500,"derivative":{"exercise_price":1.82,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-23-019461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315223019461/ownership.xml","form_type":"4"}},{"id":2146899,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":78614,"kind":"person","name":"Gilbert Mark John","position":1,"cik":"0001897698","reported_name":"Gilbert Mark John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T20:30:42.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on September 30, 2023."}],"balance_after":13750,"derivative":{"exercise_price":2.16,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001493152-22-027439","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222027439/ownership.xml","form_type":"4"}},{"id":2480138,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":78614,"kind":"person","name":"Gilbert Mark John","position":1,"cik":"0001897698","reported_name":"Gilbert Mark John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-09T02:58:45.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent of the stock options vest and become exercisable on December 1, 2022."}],"balance_after":20000,"derivative":{"exercise_price":5.35,"expiration_date":"2031-12-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-21-030884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221030884/ownership.xml","form_type":"4"}}]}